These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14659468)

  • 1. Gene microarray analysis of multiple sclerosis lesions.
    Lock CB; Heller RA
    Trends Mol Med; 2003 Dec; 9(12):535-41. PubMed ID: 14659468
    [No Abstract]   [Full Text] [Related]  

  • 2. An array of sunshine in multiple sclerosis.
    Dyment DA; Ebers GC
    N Engl J Med; 2002 Oct; 347(18):1445-7. PubMed ID: 12409550
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene microarrays and experimental demyelinating disease: a tool to enhance serendipity.
    Steinman L
    Brain; 2001 Oct; 124(Pt 10):1897-9. PubMed ID: 11571209
    [No Abstract]   [Full Text] [Related]  

  • 4. An array of possibilities for multiple sclerosis.
    Tompkins SM; Miller SD
    Nat Med; 2002 May; 8(5):451-3. PubMed ID: 11984584
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomics in multiple sclerosis--current state and future directions.
    Comabella M; Martin R
    J Neuroimmunol; 2007 Jul; 187(1-2):1-8. PubMed ID: 17400297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis.
    Ibrahim SM; Mix E; Böttcher T; Koczan D; Gold R; Rolfs A; Thiesen HJ
    Brain; 2001 Oct; 124(Pt 10):1927-38. PubMed ID: 11571211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and gene expression profiling.
    Steinman L
    Adv Exp Med Biol; 2001; 490():109-12. PubMed ID: 11505968
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomic and proteomic analysis of multiple sclerosis. Opinion.
    Robinson WH; Utz PJ; Steinman L
    Curr Opin Immunol; 2003 Dec; 15(6):660-7. PubMed ID: 14630200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.
    Lock C; Hermans G; Pedotti R; Brendolan A; Schadt E; Garren H; Langer-Gould A; Strober S; Cannella B; Allard J; Klonowski P; Austin A; Lad N; Kaminski N; Galli SJ; Oksenberg JR; Raine CS; Heller R; Steinman L
    Nat Med; 2002 May; 8(5):500-8. PubMed ID: 11984595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis.
    Mathisen PM; Kawczak JA; Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 2001 Jun; 64(5):542-51. PubMed ID: 11391709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-1 in myelin repair.
    Rinaldi M; Thomas L; Pasquini LA
    Oncotarget; 2016 Dec; 7(50):81979-81980. PubMed ID: 27876697
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function.
    Montague P; McCallion AS; Davies RW; Griffiths IR
    Dev Neurosci; 2006; 28(6):479-87. PubMed ID: 17028425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.
    Mycko MP; Papoian R; Boschert U; Raine CS; Selmaj KW
    Clin Neurol Neurosurg; 2004 Jun; 106(3):223-9. PubMed ID: 15177772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
    Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V
    Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction.
    Nicot A; Ratnakar PV; Ron Y; Chen CC; Elkabes S
    Brain; 2003 Feb; 126(Pt 2):398-412. PubMed ID: 12538406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemistry and biochemistry of myelin.
    Davison AN; Cuzner ML
    Br Med Bull; 1977 Jan; 33(1):60-6. PubMed ID: 64271
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.
    Chabas D; Baranzini SE; Mitchell D; Bernard CC; Rittling SR; Denhardt DT; Sobel RA; Lock C; Karpuj M; Pedotti R; Heller R; Oksenberg JR; Steinman L
    Science; 2001 Nov; 294(5547):1731-5. PubMed ID: 11721059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis CD49d
    Piatek P; Namiecinska M; Domowicz M; Wieczorek M; Michlewska S; Matysiak M; Lewkowicz N; Tarkowski M; Lewkowicz P
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
    Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
    J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.